ACXP vs. GDE
ACXP (Acurx Pharmaceuticals, Inc.) is a stock, while GDE (WisdomTree Efficient Gold Plus Equity Strategy Fund) is Gold fund actively managed by WisdomTree. Over the past 3 years, ACXP returned -66.70%/yr vs 39.54%/yr for GDE. At a 0.14 correlation, their price movements are largely independent.
Performance
ACXP vs. GDE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACXP achieves a -36.55% return, which is significantly lower than GDE's -1.12% return.
ACXP
- 1D
- 5.33%
- 1M
- 0.64%
- 6M
- -43.17%
- YTD
- -36.55%
- 1Y
- -83.30%
- 3Y*
- -66.70%
- 5Y*
- -57.89%
- 10Y*
- —
GDE
- 1D
- -3.15%
- 1M
- -4.15%
- 6M
- -7.79%
- YTD
- -1.12%
- 1Y
- 32.65%
- 3Y*
- 39.54%
- 5Y*
- —
- 10Y*
- —
ACXP vs. GDE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | -36.55% | -84.71% | -78.75% | -3.77% | 6.99% |
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | -1.12% | 73.76% | 44.79% | 33.85% | -8.58% |
Correlation
The correlation between ACXP and GDE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Mar 17, 2022 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACXP vs. GDE — Risk / Return Rank
ACXP
GDE
ACXP vs. GDE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACXP | GDE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.52 | ||
| Sortino ratioReturn per unit of downside risk | -2.10 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.21 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.45 | -2.42 |
| Martin ratioReturn relative to average drawdown | -1.29 | 3.55 | -4.84 |
Loading charts...
Drawdowns
ACXP vs. GDE - Drawdown Comparison
The maximum ACXP drawdown since its inception was -99.14%, which is greater than GDE's maximum drawdown of -32.01%. Use the drawdown chart below to compare losses from any high point for ACXP and GDE.
Loading charts...
Drawdown Indicators
| ACXP | GDE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.14% | -32.01% | -67.13% |
Max Drawdown (1Y)Largest decline over 1 year | -85.94% | -22.66% | -63.28% |
Max Drawdown (3Y)Largest decline over 3 years | -98.83% | -22.66% | -76.17% |
Max Drawdown (5Y)Largest decline over 5 years | -98.90% | — | — |
Current DrawdownCurrent decline from peak | -99.00% | -20.00% | -79.00% |
Average DrawdownAverage peak-to-trough decline | -69.84% | -8.11% | -61.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.45% | 9.22% | +55.23% |
Volatility
ACXP vs. GDE - Volatility Comparison
Acurx Pharmaceuticals, Inc. (ACXP) has a higher volatility of 23.76% compared to WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE) at 9.33%. This indicates that ACXP's price experiences larger fluctuations and is considered to be riskier than GDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACXP | GDE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.76% | 9.33% | +14.43% |
Volatility (6M)Calculated over the trailing 6-month period | 120.05% | 26.26% | +93.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 187.33% | 30.73% | +156.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 139.98% | 27.13% | +112.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.49% | 27.13% | +113.36% |
Dividends
ACXP vs. GDE - Dividend Comparison
ACXP has not paid dividends to shareholders, while GDE's dividend yield for the trailing twelve months is around 4.37%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | 4.37% | 4.32% | 7.14% | 2.22% | 0.81% |
Frequently Asked Questions
ACXP and GDE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACXP has higher volatility (23.76%) compared to GDE (9.33%). In terms of maximum drawdown, ACXP dropped -99.14% vs GDE's -32.01%.
GDE currently has the higher Sharpe Ratio (1.07 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACXP and GDE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer